Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the first week-6 assessment. Over half of patients reached ASCT after ...
Working at scales both simultaneously vast and incomprehensively nanoscopic, a team of thousands of designers, contractors, and craft workers delivered Intel’s 2.9-million-sq-ft chip fabrication ...
In military aviation, the runway has always been a tether. It provides the distance ...
Working at scales both simultaneously vast and incomprehensively nanoscopic, a team of thousands of designers, contractors, and craft workers delivered Intel’s 2.9-million-sq-ft chip fabrication ...